Occasional Digest

Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing

Finance Desk

machine that makes capsules in a pharmaceutical laboratory - 3D rendering

Thibault Renard/iStock via Getty Images

  • Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN) are among seven drug companies selected by the US FDA to become a part of the FDA PreCheck Pilot Program, which is designed to improve US drug manufacturing capabilities.
  • The program provides “earlier FDA

Source link

Exit mobile version